세포배양 배지 및 세포주 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Cell Culture Media & Cell Lines Market Size, Share & Trends Analysis Report By Product (Traditional Cell Lines, Classical Media), By Application (Biopharmaceutical Production, Diagnostics), By End-use, By Region, And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,356,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,760,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,569,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

세포배양 배지 및 세포주 시장 개요

세계 세포배양 배지 및 세포주 시장 규모는 2024년 50억 2,000만 달러로 평가되었습니다. 2033년에는 112억 5,000만 달러에 달하고, 2025-2033년 9.63%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이러한 성장의 원동력은 바이오 의약품에 대한 수요 증가, 재생의료 및 암 연구에 대한 투자 증가, 세포 기반 기술의 발전입니다.

또한, 신약 개발, 백신 생산, 개인 맞춤형 의료에 세포배양 적용 확대가 시장 성장을 견인할 것으로 예측됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세계의 세포배양 배지 및 세포주 시장 변수와 동향

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/보조적인 시장 전망.
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 세포배양 배지 및 세포주 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 세계의 세포배양 배지 및 세포주 시장 : 제품 추정·동향 분석

• 제품 부문 대시보드
• 세계의 세포배양 배지 및 세포주 시장 제품 변동 분석
• 세계의 세포배양 배지 및 세포주 시장 규모와 동향 분석(제품별, 2021-2033년)
• 기존 세포주
• 클래식 미디어
• 줄기세포 및 혈액 유래 세포
• 특수 미디어 제품

제5장 세계의 세포배양 배지 및 세포주 시장 : 용도 추정·동향 분석

• 용도 부문 대시보드
• 세계의 세포배양 배지 및 세포주 시장 용도 변동 분석
• 세계의 세포배양 배지 및 세포주 시장 규모와 동향 분석(용도별, 2021-2033년)
• 바이오의약품 제조
• 진단
• 약제 스크리닝 및 개발
• 조직공학 및 재생의료
• 기타 용도

제6장 세계의 세포배양 배지 및 세포주 시장 : 최종 용도 추정·동향 분석

• 최종 용도 부문 대시보드
• 세계의 세포배양 배지 및 세포주 시장 최종 용도 변동 분석
• 세계의 세포배양 배지 및 세포주 시장 규모와 동향 분석(최종 용도별, 2021-2033년)
• 대형 바이오의약품 기업
• 중소규모 바이오테크놀러지 기업
• 수탁 연구 제조 기관(CRO/CMO)
• 연구 및 학술기관
• 병원 및 진단실험실
• 기타 용도

제7장 세포배양 배지 및 세포주 시장 : 지역 추정·동향 분석

• 지역 대시보드
• 시장 규모와 예측 및 동향 분석, 2021-2033년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 기업/경쟁 분류
• 전략 매핑
• 기업 시장 현황 분석, 2024년
• 기업 개요/상장기업
  • Sartorius AG
  • Danaher
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • FUJIFILM Corporation
  • Lonza
  • STEMCELL Technologies
  • PromoCell GmbH
  • ATCC
  • AllCells.

LSH

영문 목차

영문목차

Cell Culture Media & Cell Lines Market Summary

The global cell culture media & cell lines market size was estimated at USD 5.02 billion in 2024, and is projected to reach USD 11.25 billion by 2033, growing at a CAGR of 9.63% from 2025 to 2033. This growth is driven by the rising demand for biopharmaceuticals, increasing investments in regenerative medicine and cancer research, and advancements in cell-based technologies.

Moreover, the expanding applications of cell culture in drug discovery, vaccine production, and personalized medicine are expected to boost market growth.

Global Cell Culture Media & Cell Lines Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell culture media & cell lines market report based on product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Traditional Cell Lines
• Classical Media
• Stem Cells & Blood-derived Cells
• Specialty Media Products
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Production
• Diagnostics
• Drug Screening and Development
• Tissue Engineering and Regenerative Medicine
• Other Applications
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Large Biopharmaceutical Companies
• Small and Mid-sized Biotechnology Companies
• Contract Research and Manufacturing Organizations (CROs/CMOs)
• Research and Academic Institutes
• Hospitals and Diagnostic Laboratories
• Other End Uses
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Global Cell Culture Media & Cell Lines Market Variables & Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising Vaccine Demand and Scaling of Production Capacities
    • 3.2.1.2. Growing R&D Investments
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Specialized Infrastructure and Skilled Professionals
    • 3.2.2.2. High Production Costs
• 3.3. Cell Culture Media & Cell Lines Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Global Cell Culture Media & Cell Lines Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Cell Culture Media & Cell Lines Market Product Movement Analysis
• 4.3. Global Cell Culture Media & Cell Lines Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Traditional Cell Lines
  • 4.4.1. Traditional Cell Lines Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.5. Classical Media
  • 4.5.1. Classical Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.6. Stem Cells & Blood-derived Cells
  • 4.6.1. Stem Cells & Blood-derived Cells Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.7. Specialty Media Products
  • 4.7.1. Specialty Media Products Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)

Chapter 5. Global Cell Culture Media & Cell Lines Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Cell Culture Media & Cell Lines Market Application Movement Analysis
• 5.3. Global Cell Culture Media & Cell Lines Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Biopharmaceutical Production
  • 5.4.1. Biopharmaceutical Production Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 5.5. Diagnostics
  • 5.5.1. Diagnostics Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 5.6. Drug Screening and Development
  • 5.6.1. Drug Screening and Development Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 5.7. Tissue Engineering and Regenerative Medicine
  • 5.7.1. Tissue Engineering and Regenerative Medicine Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 5.8. Other Applications
  • 5.8.1. Other Applications Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Estimates And Forecasts 2021 to 2033 (USD Million)

Chapter 6. Global Cell Culture Media & Cell Lines Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global Cell Culture Media & Cell Lines Market End Use Movement Analysis
• 6.3. Global Cell Culture Media & Cell Lines Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Large Biopharmaceutical Companies
  • 6.4.1. Large Biopharmaceutical Companies Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 6.5. Small and Mid-sized Biotechnology Companies
  • 6.5.1. Small and Mid-sized Biotechnology Companies Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 6.6. Contract Research and Manufacturing Organizations (CROs/CMOs)
  • 6.6.1. Contract Research and Manufacturing Organizations (CROs/CMOs) Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 6.7. Research and Academic Institutes
  • 6.7.1. Research and Academic Institutes Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 6.8. Hospitals and Diagnostic Laboratories
  • 6.8.1. Hospitals and Diagnostic Laboratories Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 6.9. Other End Uses
  • 6.9.1. Other End Uses Market Estimates And Forecasts 2021 to 2033 (USD Million)

Chapter 7. Cell Culture Media & Cell Liness Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. UK Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Germany Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Australia Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Thailand Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. South Korea Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait Cell Culture Media & Cell Liness Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Sartorius AG
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Danaher
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Merck KGaA
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Thermo Fisher Scientific, Inc.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. FUJIFILM Corporation
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Lonza
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. STEMCELL Technologies
    • 8.4.7.1. Company overview
    • 8.4.7.2. Product benchmarking
    • 8.4.7.3. Strategic initiatives
  • 8.4.8. PromoCell GmbH
    • 8.4.8.1. Company overview
    • 8.4.8.2. Product benchmarking
    • 8.4.8.3. Strategic initiatives
  • 8.4.9. ATCC
    • 8.4.9.1. Company overview
    • 8.4.9.2. Product benchmarking
    • 8.4.9.3. Strategic initiatives
  • 8.4.10. AllCells.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Product benchmarking
    • 8.4.10.3. Strategic initiatives

관련자료